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Purpose: The purpose of this study was to investigate responses to toxic cellular stresses in different human ocular
epithelia.
Methods:  Reactivity  with  a  specific  anti-P2X7  antibody  was  studied  using  confocal  fluorescence  microscopy  on
conjunctival, corneal, lens, and retinal cell lines as well as using impression cytology on human ocular cells. Activation
of the P2X7 receptor by selective agonists (ATP and benzoylbenzoyl-ATP) and inhibition by antagonists (oATP, KN-62,
and  PPADS)  were  evaluated  using  the  quinolinium,4-[(3-methyl-2-(3H)-benzoxazolylidene)  methyl]-1-[3-
(triethylammonio)propyl]di-iodide (YO-PRO-1) test in cytofluorometry. Different specific stresses were then induced by
a chemical toxin (benzalkonium chloride) and a chemical oxidant (tert-butyl hydroperoxide) to assess the role of the P2X7
receptor. Modulation of P2X7 receptor activation was performed with several ionic solutions.
Results: Our data show that four cell lines express the P2X7 cell death purinergic receptor as judged by reactivity with a
specific anti-P2X7 antibody, activation by the selective P2X7 agonist benzoylbenzoyl-ATP and to a lesser extent by ATP
(YO-PRO-1 dye uptake), and inhibition by three antagonists (oATP, KN-62, and PPADS). Benzalkonium chloride, a
widely used preservative, induced dramatic membrane permeabilization through P2X7 pore opening on conjunctival and
corneal epithelia. Reactive oxygen species, induced by tert-butyl hydroperoxide, lead to P2X7 receptor activation on
retinal pigment epithelium. Modulation of P2X7 receptor activation was obtained with extracellular Ca2+ and Mg2+ and
with a controlled ionization marine solution rich in different divalent cations. This marine solution could be proposed as
a new ophthalmic solution.
Conclusions: Our observations reveal a novel pathway for epithelial cells apoptosis/cytolysis by inducing different toxic
stresses and their modulation by using ionic solutions.
P2X  receptors  are  ligand-gated  ion  channels  that  are
activated by extracellular ATP. Their activation results in the
opening of a cationic channel with significant permeability to
calcium and intracellular depolarization [1,2]. P2X receptors
have  two  transmembrane  domains  with  short  intracellular
NH2- and COOH-termini. The last member of this family, the
P2X7 receptor, differs from the other P2X receptors in a distal
COOH-terminal region. Truncations in this region result in
non-functional receptors with no cell surface expression [3].
Exposure to ATP or to the more potent agonist, 2’-3′-O-
(4-benzoyl)benzoyl-ATP  (BzATP),  renders  the  P2X7
receptor  permeant  to  ions,  and  repeated  or  prolonged
application  of  either  agonists  induces  the  formation  of  a
cytolytic pore that is permeable to larger molecules (up to 900
Da)  such  as  fluorescent  dyes  quinolinium,4-[(3-methyl-2-
(3H)-benzoxazolylidene)  methyl]-1-[3-
(triethylammonio)propyl]di-iodide (YO-PRO-1) within a few
seconds [4,5]. One of the characteristic features of the P2X7
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receptor is its inhibition by extracellular divalent cations [2,
4,6,7].
The P2X7 receptor is expressed in very different tissues,
and its activation can trigger multiple cellular responses. The
P2X7  receptor  is  implicated  in  inflammation  through  the
induction  of  pro-inflammatory  cytokine  release  (mainly
interleukin-1 and interleukin-6) [8,9]. Furthermore, the P2X7
receptor can play a key role in apoptosis and cytolysis through
the  activation  of  caspases,  p38  mitogen-activated  protein
(MAP) kinase, extracellular signal-regulated kinases (ERKs),
and c-Jun kinase [10-12].
The eye is a very sensitive organ that is the site of a wide
range  of  disorders.  Not  only  can  the  active  principle  of
medications  be  responsible  for  eye  irritation  but  also  the
excipients [13]. For example, the toxicity of the benzalkonium
chloride (BAC) preservative, a quaternary ammonium, has
been widely documented [14-16]. Long-term treatment with
preserved eye drops can lead to the deepithelialization of the
ocular surface [17].
The retinal pigment epithelium monolayer is at risk for
oxidative damage due to its location in a highly oxygenated
environment and its exposure to high levels of visible light.
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889Although  visible  light  does  not  damage  cells  by  directly
interacting  with  DNA  and  most  proteins,  it  can  lead  to
oxidation of key constituents via reactions with endogenous
photosensitizers.  Retinal  epithelium  is  therefore  likely  to
accumulate oxidative damage over time, which is believed to
cause tissue dysfunction that may contribute to diseases of
aging.
Ocular epithelia can then be damaged by a wide range of
exogenous  chemical  and  physical  toxic  agents,  but  the
induced cell mechanisms remain unknown.
Gröschel-Stewart et al. [18] identified the P2X7 receptor
in  numerous  epithelia  in  the  rat  including  the  cornea,
esophagus,  soft  palate,  tongue,  vagina,  and  foot  pad,
concluding that P2X7 receptor could represent a target for the
development of therapeutics in the treatment of epithelial
dysfunctions. To our knowledge, no study has been run on
human epithelia. Our aim was to study the P2X7 receptor in
four human ocular epithelia to evaluate its implication in
different toxicological pathologies. The potency of several
ionic solutions to modulate P2X7 receptor activation was also
assessed.
METHODS
Reagents: Materials for cell culture were provided by Eurobio
(Les Ulis, France). ATP, BzATP, oATP (2',3′,-dialdehyde
ATP),  PPADS  (pyridoxal-phosphate-6-azophenyl-2′,4′-
disulphonic  acid),  KN-62  (1-(N,O-bis[5-
isoquinolinesulphonyl]-N-methyl-L-tyrosyl)-4-
phenylpiperazine),  benzalkonium  chloride,  tert-butyl
hydroperoxide, CaCl2, MgCl2, anti-P2X7 receptor antibody,
mouse anti-rabbit IgG-FITC conjugate, ATP bioluminescent
assay  kit,  and  neutral  red  dye  were  from  Sigma-Aldrich
(Saint-Quentin  Fallavier,  France).  Alexa  Fluor®  488  goat
anti-rabbit  IgG,  propidium  iodide,  YO-PRO-1,  and  2’,7’-
dichlorofluorescein diacetate were purchased from Invitrogen
(Carlsbad, CA). Brilliant Blue G (BBG) was purchased from
Bio-Rad (Richmond, CA).
The controlled ionization marine solution (Lacrymer®)
was purchased from Yslab (Quimper, France).
Cell culture: A human conjunctival cell line (WKD, ECACC
93120839)  was  cultured  under  standard  conditions  (moist
atmosphere of 5% CO2 at 37 °C) in Dulbecco’s minimum
essential  medium  (DMEM)  supplemented  with  10%  fetal
bovine serum (FBS), 2 mM L-glutamine, 50 IU/ml penicillin,
and 50 IU/ml streptomycin. The medium was changed every
three  days.  Confluent  cultures  were  removed  by  trypsin
incubation, and then cells were counted. They were seeded
into 96-well culture microplates at a density of 90,000 cells
per well for microtitration analysis. Cultures were kept at
37 °C for 24 h.
A human corneal cell line (HCE, RCB 1384) [19] was
cultured under standard conditions in a mixture 1:1 of DMEM
and Nutrient Mixture F12 supplemented with 10% FBS, 2 mM
L-glutamine, 50 IU/ml penicillin, and 50 IU/ml streptomycin.
The medium was changed every two days. Confluent cultures
were  removed  by  trypsin  incubation,  and  then  cells  were
counted. They were seeded into 96 well culture microplates
at a density of 70,000 cells per well and were kept at 37 °C
for 24 h.
A  human  retinal  pigmented  epithelium  cell  line
(ARPE-19, ATCC CRL2302) was cultured in a mixture 1:1
of DMEM and Nutrient Mixture F12 supplemented with 10%
FBS, 2 mM L-glutamine, 50 IU/ml penicillin, and 50 IU/ml
streptomycin.  The  medium  was  changed  every  two  days.
Confluent cultures were removed by trypsin incubation, and
then cells were counted. They were seeded into 96 well culture
microplates at a density of 20,000 cells/ml and kept at 37 °C
for 24 h.
A human lens epithelial (HLE) cell line, SRA 01/04,
obtained from Washington University, (St Louis, MO) was
cultured under standard conditions in 1% glucose DMEM
supplemented with 15% FBS, 2 mM glutamine, and 4 µg/ml
gentamicin.  They  were  seeded  into  96  well  culture
microplates at a density of 30,000 cells per well and were kept
at 37 °C for 24 h.
Impression cytology (ex vivo human conjunctival epithelium):
Informed  consent  that  was  approved  by  the  Institutional
Review Board was obtained from each normal volunteer, and
research  was  performed  according  to  the  tenets  of  the
Declaration of Helsinki. Criteria for participation included
persons of either gender, at the age of 18 years or older, and
with no known external ocular disorders.
To obtain specimens, a paper filter (Gelman Supor®, Pall
Sciences, Saint-Germain-en-Laye, France) was applied on the
conjunctiva to collect the most superficial layers of the ocular
surface. The paper filter was then allowed to dry completely
for at least 24 h.
P2X7 receptor localization by confocal microscopy: Cell lines
were  cultured  on  slides  (Laboratory-tek  II  chambered
coverglass;  Nalge  Nunc  International,  Naperville,  IL).
Culture cells and impression cytology specimens were fixed
with 4% paraformaldehyde and permeabilized with Triton
X-100. Cells were immersed for 30 min in 1% BSA followed
by a 1 h incubation time with the rabbit anti-P2X7 receptor
antibody.  Cells  were  then  incubated  with  a  secondary
antibody, Alexa Fluor® 488 goat anti-rabbit IgG, for 1 h at
room temperature. Propidium iodide was added to mark cell
nuclei before examination with a confocal epifluorescence
microscope (E800, PCM 2000; Nikon, Tokyo, Japan).
ATP  release  evaluation  by  luminescence:  Quantitative
determination  of  ATP  was  assessed  using  the  ATP
bioluminescent assay kit from Sigma-Aldrich. Briefly, the
cells were incubated with BAC for 15 min, and supernatants
were collected for ATP quantification. Luminescence was
measured using a spectral scanning reader (Varioskan Flash,
Thermo Electron Corporation, Saint-Herblain, France).
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Experiments were conducted using microplate fluorometry,
which allows fluorometric detection (230–1000 nm) with high
sensitivity (pg-fg/ml; Safire™; Tecan, Lyon, France). This
technique allows the use of fluorescent probes directly on
living cells and detects the fluorescent signal directly in the
microplate in less than 1 min (for a 96 well microplate).
YO-PRO-1, a DNA probe, only enters apoptotic cells
after P2X7 receptor activation-induced pore formation. A 2-
μM YO-PRO-1 solution in phosphate buffer saline (PBS) was
distributed in the wells (200 μl per well), and the microplate
was placed at room temperature in the dark. After 10 min, the
fluorescence signal was scanned (excitation [ex]=491 nm;
emission [em]=509 nm). For kinetic studies, YO-PRO-1 dye
was directly diluted in the xenobiotic solutions.
Cell  viability  and  oxidative  stress  evaluation  by
microcytofluorometry: Membrane integrity, which is closely
correlated with cell viability, was evaluated with neutral red
(NR) using fluorometric detection (ex=535 nm; em=600 nm).
Reactive oxygen species (ROS) were detected with the
2’,7’-dichlorofluorescein diacetate probe (DCFH-DA). The
fluorescent signal (ex=485 nm; em=535 nm) is proportional
to ROS production.
Data  analysis:  Data  in  the  text  and  graphs  are  shown  as
relative fluorescence units or as fluorescence percentage of
the control, and statistical analyses were performed using one-
way ANOVA followed by Dunnett’s test (α risk=0.05). Each
test was performed in triplicate.
RESULTS
P2X7 receptor expression and activation on ocular surface:
P2X7  expression  was  confirmed  by  confocal  microscopy
analysis. Figure 1A,B show strong labeling of conjunctival
and corneal cell membrane using specific anti-P2X7 antibody
that raised against the COOH-terminal epitope of the P2X7
receptor  protein.  Figure  1C  shows  immunoreactivity  of
human conjunctival cells from impression cytology. Isotype
control monoclonal antibody was used to estimate the non-
specific binding of target primary antibodies to cell surface
antigens (data not shown).
Changes in conjunctival and corneal plasma membrane
permeability due to stimulation with ATP and BzATP (which
has a higher affinity for the P2X7 receptor) are shown in
Figure 2A,B, respectively. As expected, BzATP induced a
faster and more important permeabilization than ATP on both
cell lines.
Different P2X7 receptor inhibitors were tested for their
ability to block ATP or BzATP stimulation (Figure 3). Figure
3A shows that when pre-incubated for 2h, oATP (50 µM, 100
µM, and 500 µM) is able to significantly decrease YO-PRO-1
dye uptake after ATP stimulation by −41%, −33%, and 35%,
respectively  (no  significant  different  between  the  three
values). KN-62 (100 µM) and PPADS (500 µM) were pre-
incubated for 30 min and show almost the same inhibition
effect on P2X7 receptor stimulation (Figure 3B,C); they both
induce an ~65% decrease in YO-PRO-1 uptake.
P2X7 receptor implication in an iatrogenic pathology: ATP
release after BAC incubation on conjunctival cells is shown
in Figure 4A. After 15 min, BAC 0.002% induced a high ATP
release in extracellular medium compared to PBS.
Figure 4A,B show BAC-induced permeabilization of the
plasma  membrane  of  conjunctival  and  corneal  cells,
respectively. YO-PRO-1/neutral red ratio was calculated to
take into account the number of living cells responsible for
YO-PRO-1 uptake. The lowest BAC concentration (0.001%)
induced a P2X7 receptor activation leading to pore opening
and YO-PRO-1 dye influx in both cell lines. When the cells
Figure 1. Expression of P2X7 receptor on human conjunctival and
corneal epithelial cells. Conjunctival cell line (A), corneal cell line
(B) and cells from ocular surface impression cytology (C) presented
P2X7 receptor expression. Cells were fixed, permeabilized, and then
incubated with a P2X7 antibody. Nuclei were stained with propidium
iodide. Cells were observed using the confocal microscopy.
Figure 2. P2X7 receptor activation by ATP and BzATP. ATP and
BzATP cause YO-PRO-1 dye uptake in conjunctival (A) and corneal
cells  (B).  Cells  were  incubated  with  ATP  or  BzATP  solutions
containing YO-PRO-1.
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891were  pre-incubated  with  10  µM  BBG  (P2X7  receptor
antagonist)  before  BAC,  membrane  permeabilization  was
inhibited  on  conjunctival  cells  (118%,  not  statistically
different  compared  to  PBS  control)  and  on  corneal  cells
(153% compared to PBS control versus 201% without BBG).
At 0.001% BAC, corneal cells seem to be more sensitive
than conjunctival cells since BAC induced a higher increase
in YO-PRO-1 fluorescence signal on the cornea than on the
conjunctiva (201% versus 136%, respectively, compared to
the control). At 0.004% BAC, conjunctival cells seem to be
more  sensitive  than  corneal  cells  (912%  versus  485%,
respectively, compared to the control). After incubation with
0.02% BAC on conjunctival cells and incubation with 0.05%
BAC  on  corneal  cells,  the  permeabilization  reaches  its
maximum  since  YO-PRO-1  uptake  does  not  increase
compared to the lower BAC concentrations.
P2X7 receptor expression and activation on retinal pigment
epithelium:  Retinal  pigment  epithelial  cells  expressed  the
P2X7 receptor protein as shown in Figure 5A. Isotype control
monoclonal antibody was used to estimate the non-specific
binding of target primary antibodies to cell surface antigens
(data not shown). ATP and BzATP stimulated P2X7 receptor
activation (an increase in YO-PRO-1 dye uptake) with a more
potent effect with BzATP than ATP (Figure 5B).
P2X7  receptor  implication  in  oxidative  stress:  Tert-butyl
hydroperoxide (tBHP) was chosen to induce oxidative stress
on retinal pigment epithelial cells (Figure 6). tBHP (10 µM)
induced neither ROS production nor P2X7 permeabilization.
ROS overproduction appeared after 1 h incubation time with
Figure 3. Results of YO-PRO-1 dye uptake test. oATP was pre-
incubated for 2 h before ATP incubation and decreased YO-PRO-1
uptake (A); KN-62 was pre-incubated for 30 min before BzATP
incubation and decreased YO-PRO-1 uptake (B); PPADS was pre-
incubated 30 min before ATP incubation and decreased YO-PRO-1
uptake (C).
50 µM tBHP whereas P2X7 permeabilization occurred after
Figure 4. Effects of BAC on ocular surface cells. BAC induces ATP
release in extracellular medium (A). The cells were incubated with
0.002%  BAC  for  15  min.  Supernatants  were  collected  for  ATP
quantification. BAC induces high YO-PRO-1 uptake in conjunctival
(B) and corneal (C) cells. Frame: Cells were pre-incubated with 10
μM BBG for 30 min before 0.001% BAC and YO-PRO-1 incubation.
BBG  inhibited  YO-PRO-1  uptake  induced  by  BAC  on  both
conjunctival  (A)  and  corneal  (B)  cells.  The  asterisk  indicates  a
p<0.05 compared to PBS and the triple asterisk denotes a p<0.001
compared to PBS.
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892incubation with 100 µM tBHP.
P2X7  receptor  expression  and  activation  on  lens:  P2X7
receptor expression and activation were also evaluated on lens
cells.  Figure  7A  shows  P2X7  protein  localization  using
confocal microscopy (isotype control antibody was used to
estimate the non-specific binding, data not shown), and Figure
7B confirms P2X7 receptor activity using the YO-PRO-1
uptake test after stimulation with ATP and BzATP. BzATP
concentration (600 µM on lens cells) was 4–12 times higher
than  the  concentrations  used  to  stimulate  corneal,
conjunctival, and retinal cells.
P2X7 receptor modulation with an ionic marine solution: As
P2X7 receptor is a non-selective ion channel, the influence of
divalent cations on P2X7 permeabilization was tested. PBS is
Figure  5.  P2X7  receptor  expression  and  activation  on  retinal
epithelial cells. Cells were fixed, permeabilized, and then incubated
with a P2X7 antibody (A). Nuclei were stained with propidium
iodide. Cells were observed using the confocal microscopy. P2X7
receptor  activation  by  ATP  and  BzATP  causes  YO-PRO-1  dye
uptake in retinal cells (B).
commercially  available  with  or  without  calcium  and
magnesium, so both types of PBS were incubated with cells.
PBS containing calcium and magnesium (PBS +Ca, +Mg)
induced less P2X7 basal permeabilization than PBS without
calcium and magnesium (PBS -Ca, -Mg). MgCl2 and CaCl2
were  dissolved  in  PBS  -Ca,  -Mg  to  the  concentration
corresponding  to  PBS  +Ca,  +Mg  (0.5  mM  and  0.9  mM,
respectively). Figure 8 shows a synergic effect between Mg2+
and  Ca2+,  leading  to  a  50%  decrease  in  the  YO-PRO-1
fluorescence  signal,  whereas  separately,  Mg2+  and  Ca2+
induced 14% and 32% decreases in the fluorescence signal,
respectively.  Since  divalent  cations  seem  to  significantly
modulate  membrane  permeabilization,  the  effect  of  a
controlled ionization marine solution (derivative of sterile sea
water)  was  studied  (Figure  9).  The  controlled  ionization
marine solution decreased YO-PRO-1 uptake in the four cell
lines compared to PBS.
DISCUSSION
The P2X7 receptor has been cloned and sequenced [2,20,21].
Its structure is well known, but the role of this receptor in
ocular epithelia has not yet been studied yet. The expression
of P2X7 receptor has so far been reported in immune cells,
but little is known about its presence in epithelial cell types.
According to our results, P2X7 receptor is expressed in
the four human epithelial cell lines we tested. Furthermore,
we demonstrated the presence of P2X7 receptor in an original
human  ex  vivo  model,  epithelial  cells  from  impression
cytology. The ability of ATP and BzATP to induce P2X7 pore
opening was confirmed using 376 Da impermeant dye uptake
(YO-PRO-1). Three different inhibitors were tested for their
ability to block P2X7 receptor activation; they all decreased
membrane permeabilization induced by ATP or BzATP. Most
Figure 6. Effects of tBHP (chemical oxidant) on retinal epithelial
cells.  ROS  overproduction  (dashed  line)  and  P2X7  receptor
activation (full line) are induced by tBHP on retinal cells. Cells were
exposed to various concentrations of tBHP for 1 h. ROS production
and  P2X7  pore  formation  were  detected  using  the  H2DCF-DA
(dashed line) and YO-PRO-1 (full line) tests. The asterisk denotes a
p<0.05 and the triple asterisk indicates a p<0.001 compared to PBS.
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893anti-P2X7  blockers  are  not  absolutely  specific  to  P2X7
receptors; rather they are P2X receptor inhibitors. Indeed,
oATP is not specific to P2X7 since it also blocks currents at
P2X1 and P2X2 receptors [22]. PPADS and KN-62 are much
more specific to the human P2X7 receptor [23,24].
P2X7 receptor is present and functional on human ocular
epithelial cells: Conjunctival and corneal epithelia are very
sensitive  to  external  toxins  far  more  than  epidermal
epithelium. At the moist surface of the body, the cornea is a
Figure 7. P2X7 receptor expression and activation on lens epithelial
cells. Cells were fixed, permeabilized, and then incubated with a
P2X7 antibody (A). Nuclei were stained with propidium iodide. Cells
were  observed  using  the  confocal  microscopy.  P2X7  receptor
activation by ATP and BzATP causes YO-PRO-1 dye uptake in lens
cells (B).
non-keratinized stratified squamous epithelium contrary to
keratin-rich epithelia. They can suffer many disorders since
they are exposed to various external influences. Apart from
physical stress, ocular medications (eye drops) are one of the
most potent hazards of the ocular surface because they are in
direct contact with the conjunctiva and the cornea. Our results
showed that BAC, the most commonly used preservative in
ophthalmology  and  in  cosmetology,  stimulated  a  loss  of
membrane  integrity  and  then  stimulated  ATP  release  in
extracellular medium. This ATP release could explain P2X7
receptor  activation  we  observed  through  membrane
permeabilization on both conjunctival and corneal cells. We
could ask if the addition of an ATP-consuming enzyme (such
as  hexokinase)  would  inhibit  BAC-induced  YO-PRO-1
uptake. We confirm our previous work, which concluded that
preserved fluoroquinolone eye drop intolerance was mainly
Figure  8.  Effects  of  extracellular  Ca2+  and  Mg2+  on  YO-PRO-1
uptake. Both Ca2+ and Mg2+ decreased YO-PRO-1 uptake but Ca2+
has a more potent effect than Mg2+. Ca2+ and Mg2+ together have a
synergic effect on the decrease in YO-PRO-1 uptake. The double
asterisk indicates a p<0.01 compared to PBS and the triple asterisk
denotes a p<0.001 compared to PBS.
Figure 9. Effects of a controlled ionization marine solution on P2X7
receptor activation. Controlled ionization marine solution (CIMS)
decreases YO-PRO-1 uptake in the four cell lines compared to PBS.
The cells were incubated with either PBS (black line) or CIMS (white
line).
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894due to P2X7 receptor activation, which was induced by BAC
[25]. BBG, a P2X7 receptor antagonist, was able to block
P2X7 activation induced by BAC. These results confirm the
role  of  the  P2X7  receptor  in  the  cytotoxic  mechanisms
induced by BAC. We showed that as the BAC concentration
increases, it becomes more hazardous for the conjunctiva.
Cytolysis, induced by BAC [16], could be explained by a high
activation  of  the  P2X7  receptor,  also  known  as  the  P2Z
cytolytic receptor [1].
It seems that the P2X7 receptor mainly acts as a pro-
apoptotic receptor in epithelia. Groschel-Stewart et al. [18]
reported  that  the  P2X7  receptor  may  play  a  role  in  the
physiologic turnover of continuously regenerating epithelial
tissue, and Greig et al. [26] observed that the P2X7 receptor
could play a role in periderm cell apoptosis. Our work showing
BAC-induced P2X7 receptor activation in the outer layers of
the ocular surface epithelia are well correlated with these
observations.
The optic nerve, which acts like a cable connecting the
eye  with  the  brain,  is  a  continuation  of  the  axons  of  the
ganglion  cells  in  the  retina.  As  ATP  can  act  as  a
neurotransmitter, high concentrations of P2X7 purinoreceptor
in retinal cells are not surprising. The P2X7 receptor has been
involved  in  neurodegenerative  diseases  [27].  The
participation of reactive oxygen species in neurodegenerative
diseases,  mainly  Alzheimer  disease,  is  well  documented
[28]. Oxidative stress is also thought to be involved in retinal
degeneration [29]. Therefore, we studied the role of P2X7
receptor in retinal cytotoxicity after oxidative stress induction.
Indeed, neurodegenerative retinal diseases such as age-related
macular degeneration (AMD) could be due to P2X7 receptor
activation in the retina. Our results showed that an oxidant
agent (tBHP) slightly induced P2X7 receptor activation. P2X7
activation was observed at higher doses of tBHP than those
used to induce ROS overproduction. Therefore, we could
imagine that ROS overproduction was responsible for P2X7
receptor activation. Effects of attacks by radicals, particularly
those produced by ROS, can accumulate over the years [30],
and ROS-induced P2X7 receptor activation could be part of
cell  death  mechanisms  that  occur  in  neurodegenerative
diseases.
The presence of an active P2X7 receptor in lens cells
confirms the possible importance of this cytolytic receptor in
different epithelial tissues.
Numerous  reports  suggest  that  the  P2X7  receptor
function  can  be  regulated  by  extracellular  ions  [2,4,6,7].
Membrane permeability to fluorescent dyes was induced by
ATP4- rather than MgATP2- [4]. It could then explain why
divalent cations have the ability to inhibit pore formation by
direct ionic interaction with the negative charges of ATP. In
our study, Ca2+ was more effective in reducing P2X7 pore
basal formation than Mg2+. This result is consistent with the
atomic mass of calcium being higher than the magnesium
atomic  mass  (40.078  against  24.305,  respectively),  which
could explain why calcium induced a higher steric inhibition.
A study on HEK293 cells stably expressing the rat P2X7
receptor showed that Mg2+ was more effective in inhibiting
ATP-induced  YO-PRO-1  uptake  than  Ca2+  [7]  whereas  a
study on HEK293 cells expressing the human P2X7 receptor
showed no significant difference between Mg2+ and Ca2+ in
their capacity to inhibit BzATP-induced YO-PRO-1 uptake
[6]. Our results, obtained with human cells, are not concordant
with those observed with rat cells, but interspecies differences
in the inhibiting effect of P2X7 receptor antagonists have
already been reported [31]. Not only cations but also anions
such as chloride can affect dye uptake [32,33]. Other possible
roles for ions is a modulation of the agonist binding site
resulting in decreased agonist affinity for the P2X7 receptor
[7] and a repression in the conformational changes that permit
assembly or activation of the pore [34].
The controlled ionization marine solution we tested is a
controlled ionization sea solution containing Ca2+, Mg2+, and
Zn2+. It inhibited basal activation of P2X7 receptor in each
tested cell line. Solutions rich in divalent cations could be
easily used in therapeutics to help in inhibiting a new class of
P2X7 receptor modulators.
These observations reveal a novel pathway for ocular
toxicity in the ocular surface as well as in the retina. The
implication of P2X7 receptor in different ocular stresses (i.e.,
preservatives and oxidative stress) confirms its pleiotropic
activities.
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